On Tuesday, Sanofi SA SNY reported data from the Phase 3 Baby-COMET study of Nexviazyme (avalglucosidase alfa). Read Also: EU ...
On Friday, Italian pharma company Recordati S.p.A agreed to acquire the global rights to Enjaymo (sutimlimab) from Sanofi SA (NASDAQ:SNY) for $825 million as an upfront payment and additional ...
Sanofi SA (NASDAQ:SNY) announced on Wednesday that it will invest at least $20 billion in the U.S. through 2030. Research and development, plus U.S. manufacturing, will receive the bulk of the ...
View Sanofi SA Sponsored ADR SNY stock quote prices, financial information, real-time forecasts, and company news from CNN.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The U.S. Food and Drug Administration (FDA) on Friday approved Sanofi SA’s SNY subcutaneous Sarclisa Escena (isatuximab-irfc) ...
Sanofi SA’s Paris headquarters were raided Tuesday by French authorities as part of a tax fraud investigation into a financing deal provided by Societe Generale SA. The French pharmaceutical giant ...
(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...
CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research ...
On June 22, Sanofi SA (NASDAQ:SNY) announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results